Novan Inc
F:6LUA
Novan Inc
F:6LUA
Price:
0.001
EUR
Market Closed
Market Cap:
€1.3k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Novan Inc
F:6LUA
|
US |
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
DK |
|
F
|
Fennec Pharmaceuticals Inc
TSX:FRX
|
US |
|
FutureFuel Corp
NYSE:FF
|
US |
|
G
|
GalaxiaMoneyTree Co Ltd
KOSDAQ:094480
|
KR |
|
Nephros Inc
NASDAQ:NEPH
|
US |
|
Fermiere du Casino Municipal Cannes SA
PAR:FCMC
|
FR |
|
First Majestic Silver Corp
TSX:FR
|
CA |
|
ARS Pharmaceuticals Inc
NASDAQ:SPRY
|
US |
|
H
|
HIVE Blockchain Technologies Ltd
NASDAQ:HIVE
|
CA |
|
GuocoLand Ltd
SGX:F17
|
SG |
|
F
|
Flexopack SA
ATHEX:FLEXO
|
GR |
|
Ascelia Pharma AB
STO:ACE
|
SE |
|
SS Lazio SpA
F:LZO1
|
IT |
|
Amdocs Ltd
NASDAQ:DOX
|
US |
|
U
|
Uzin Utz SE
SWB:UZU
|
DE |
|
BRP Group Inc
NASDAQ:BWIN
|
US |
|
F
|
Feytech Holdings Bhd
KLSE:FEYTECH
|
MY |
Balance Sheet
Balance Sheet Decomposition
Novan Inc
Novan Inc
Balance Sheet Decomposition is not available for
Novan Inc
Novan Inc
Balance Sheet
Novan Inc
Novan Inc
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
7
|
46
|
35
|
3
|
8
|
14
|
36
|
47
|
12
|
|
| Cash Equivalents |
1
|
7
|
46
|
35
|
3
|
8
|
14
|
36
|
47
|
12
|
|
| Total Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
4
|
22
|
|
| Accounts Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
4
|
22
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Current Assets |
0
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
7
|
|
| Total Current Assets |
2
|
8
|
47
|
36
|
4
|
9
|
16
|
44
|
54
|
42
|
|
| PP&E Net |
1
|
2
|
2
|
16
|
17
|
16
|
12
|
2
|
14
|
16
|
|
| PP&E Gross |
1
|
2
|
2
|
16
|
17
|
16
|
12
|
2
|
14
|
16
|
|
| Accumulated Depreciation |
2 060
|
3 053
|
2
|
2
|
3
|
5
|
6
|
1
|
2
|
3
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
27
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Total Assets |
3
N/A
|
10
+219%
|
50
+402%
|
52
+5%
|
21
-60%
|
26
+25%
|
29
+10%
|
47
+61%
|
69
+47%
|
90
+31%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
2
|
3
|
0
|
1
|
2
|
1
|
2
|
14
|
|
| Accrued Liabilities |
0
|
1
|
3
|
10
|
6
|
3
|
4
|
3
|
5
|
19
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
3
|
4
|
8
|
4
|
4
|
4
|
|
| Total Current Liabilities |
1
|
2
|
5
|
13
|
9
|
9
|
13
|
9
|
11
|
46
|
|
| Long-Term Debt |
0
|
0
|
0
|
8
|
8
|
8
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
6
|
4
|
40
|
35
|
39
|
39
|
|
| Total Liabilities |
1
N/A
|
2
+31%
|
5
+187%
|
21
+320%
|
23
+7%
|
21
-7%
|
53
+150%
|
44
-17%
|
51
+15%
|
86
+69%
|
|
| Equity | |||||||||||
| Common Stock |
20
|
38
|
105
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
19
|
30
|
63
|
123
|
160
|
172
|
204
|
249
|
279
|
310
|
|
| Additional Paid In Capital |
0
|
0
|
3
|
154
|
158
|
178
|
180
|
252
|
297
|
315
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
8
+366%
|
45
+449%
|
31
-31%
|
2
N/A
|
5
N/A
|
24
N/A
|
3
N/A
|
18
+515%
|
5
-75%
|
|
| Total Liabilities & Equity |
3
N/A
|
10
+219%
|
50
+402%
|
52
+5%
|
21
-60%
|
26
+25%
|
29
+10%
|
47
+61%
|
69
+47%
|
90
+31%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
2
|
3
|
3
|
15
|
19
|
25
|
|
Switch to:
Switch to:
See Also
Discover More
